1 study found for:    22048173 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age
Condition: Infections, Papillomavirus
Interventions: Biological: GSK Biologicals HPV 16/18 vaccine 580299 (CervarixTM);   Biological: Gardasil ® (Merck & Co. Inc);   Biological: Placebo

Indicates status has not been verified in more than two years